Parabilis Medicines, Inc.
Statements
Cash Flow
Parabilis Medicines, Inc. (PBLS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -124 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2024 | 2025 |
|---|---|---|
| -104 | -124 | |
| 2.1 | 2.5 | |
| 4.3 | 3.3 | |
| 0.9 | 9.1 | |
| 0.9 | 0.3 | |
| 30 | 40 | |
| -0.5 | -0.1 | |
| 0.0 | -3.1 | |
| 78 | 64 | |
| 4.7 | -20 | |
| -104 | -124 |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.